Healthcare
Active
Exited
ACT Biotech
Targeted, orally available cancer drugs
USA
Exit 2014
ArraVasc
Peripheral balloon catheters
Ireland
Exit 2018
cerbomed
Non-invasive vagus-nerve stimulation device against epilesy
Germany
Exit 2018
DeveloGen
Metabolic disorders
Germany
Exit 2009
IDM Pharma
Drugs against cancer
USA
Exit 2007 (“cold” IPO)
mtm Laboratories
Cancer diagnostics
Germany
Exit 2018
myoscience
Pain treatment devices
USA
Exit 2019